Israeli Capital Markets Will Experience a Renaissance in 2018
31.12.17|Steven Schoenfeld
2017 saw the largest-ever acquisition of an Israeli technology company (Mobileye) and biotech company (NeuroDerm), charting a positive course for Israeli capital markets in 2018